1AY6

THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF

Summary for 1AY6

• Entry DOI: 10.2210/pdb1ay6/pdb
• Related PRD ID: PRD_000410
• Descriptor: THROMBIN LIGHT CHAIN, THROMBIN HEAVY CHAIN, HIRUGEN, ... (5 entities in total)
• Functional Keywords: complex of serine protease-inhibitor, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• Biological source: Homo sapiens (human); More
• Cellular location: Secreted, extracellular space: P00734 P00734; Secreted: P01050
• Total number of polymer chains: 3
• Total formula weight: 36098.17

Authors

Ganesh, V.,Maryanoff, B.E.,Tulinsky, A. (deposition date: 1997-11-14, release date: 1998-03-18, Last modification date: 2024-11-20)

Primary citation

Greco, M.N.,Powell, E.T.,Hecker, L.R.,Andrade-Gordon, P.,Kauffman, J.A.,Lewis, J.M.,Ganesh, V.,Tulinsky, A.,Maryanoff, B.E.
Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif
Bioorg.Med.Chem.Lett., 6:2947-2952, 1996

PubMed Abstract: The macrocyclic peptide cyclotheonamide A (CtA), isolated from the marine sponge Theonella sp., represents an unusual class of serine protease inhibitor. A complex of this inhibitor with human alpha-thrombin, a protease central to the bioregulation of thrombosis and hemostasis, was studied by x-ray crystallography. This work (2.3-A resolution) confirms the structure of CtA and reveals intimate details about its molecular recognition within the enzyme active site. Interactions due to the "Pro-Arg motif" (Arg occupancy of the S1 specificity pocket; formation of a hydrogen-bonded two-strand antiparallel beta-sheet with Ser214-Gly216) and the alpha-keto amide group of CtA are primarily responsible for binding to thrombin, with the alpha-keto amide serving as a transition-state analogue. A special interaction with the "insertion loop" of thrombin (Tyr60A-Thr60I) is manifested through engagement of the hydroxyphenyl group of CtA with Trp60D as part of an "aromatic stacking chain." Biochemical inhibition data (Ki values at 37 degrees C) were obtained for CtA with thrombin and a diverse collection of serine proteases. Thus, CtA is just a moderate inhibitor of human alpha-thrombin (Ki = 0.18 microM) but a potent inhibitor of trypsin (Ki = 0.023 microM) and streptokinase (Ki = 0.035 microM). The relative lack of potency of CtA as a thrombin inhibitor is discussed with respect to certain structural features of the enzyme complex. We also report the total synthesis of CtA, by a convergent [2 + 3] fragment-condensation approach, to serve the preparation of cyclotheonamide analogues for structure-function studies.

PubMed: 8367461
DOI: 10.1016/S0960-894X(96)00554-9

Experimental method

X-RAY DIFFRACTION (1.8 Å)